Long Term Investments - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maat Pharma SA
Long-Term Investments Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Long-Term Investments
€200k
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanobiotix SA
PAR:NANO
Long-Term Investments
€299k
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
16%
Innate Pharma SA
PAR:IPH
Long-Term Investments
€10.4m
CAGR 3-Years
-36%
CAGR 5-Years
-22%
CAGR 10-Years
59%
Genfit SA
NASDAQ:GNFT
Long-Term Investments
€4.1m
CAGR 3-Years
41%
CAGR 5-Years
26%
CAGR 10-Years
19%
Eurobio Scientific SA
PAR:ALERS
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Long-Term Investments?
Long-Term Investments
200k EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Long-Term Investments amounts to 200k EUR.

What is Maat Pharma SA's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
26%

Over the last year, the Long-Term Investments growth was -33%. The average annual Long-Term Investments growth rates for Maat Pharma SA have been 26% over the past three years .

Back to Top